Background: Modeling studies suggest that hundreds of thousands of U.S. children have lost caregivers since the COVID-19 pandemic began. However, few studies have directly evaluated changes in mortality in the families of U.S. children using patient-level data, characterized adult decedents and their surviving children, or accounted for the loss of the adult siblings of children.

Methods: We conducted a repeated cross-sectional analysis using Optum's De-identified Clinformatics Data Mart, a national claims database that includes privately insured children and families across the U.S. We identified families of children aged 0-17 years enrolled in a family plan during each month in 2016-2021. Among these families, we calculated the proportion with ≥ 1 death of an adult family member aged ≥ 18 years enrolled in the plan, including young adult dependents aged 18-25 years. We used descriptive statistics to assess the age and sex of adult decedents and their surviving children. Moreover, we calculated the proportion of adult decedents who were the siblings of children.

Results: From January 2016 through February 2020, the median monthly proportion of families with ≥ 1 adult death was 0.000076 (7.6 per 100,000 families). This rose to 12.1 per 100,000 families in December 2020, fell below the pre-pandemic median during March-July 2021, and exceeded this median for most months during August-December 2021. Among adult decedents, 63.8% were male and mean age was 44.8 (11.4) years. Among surviving children, 59.5% were adolescents aged 12-17 years. Among adult decedents, 4.8% were the siblings of children.

Conclusions: During the pandemic, the proportion of privately insured children experiencing the loss of an adult family members varied over time, with the highest rates occurring at the end of 2020 and the second half of 2021. Some children lost adult siblings, suggesting that screening for child bereavement should include all family members, not just parents/guardians.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12889-025-21528-7DOI Listing

Publication Analysis

Top Keywords

adult decedents
20
families children
12
surviving children
12
children
11
adult
11
mortality families
8
covid-19 pandemic
8
repeated cross-sectional
8
children lost
8
decedents surviving
8

Similar Publications

Background: Modeling studies suggest that hundreds of thousands of U.S. children have lost caregivers since the COVID-19 pandemic began.

View Article and Find Full Text PDF

Introduction: Death is universal, yet relatively little is known about how Canadians experience their death. Using novel decedent interview data from the Canadian Longitudinal Study on Aging we describe the prevalence and characteristics of peace with dying among older Canadians.

Methods: We conducted a secondary analysis of decedent interview data from the Canadian Longitudinal Study on Aging.

View Article and Find Full Text PDF

Incidence of adverse outcome events rises as patients with advanced illness approach end-of-life. Exposures that tend to occur near end-of-life, for example, use of wheelchair, oxygen therapy and palliative care, may therefore be found associated with the incidence of the adverse outcomes. We propose a concept of reverse time-to-death (rTTD) and its use for the time-scale in time-to-event analysis based on partial likelihood to mitigate the time-varying confounding.

View Article and Find Full Text PDF

Distinct subcellular localization of tau and alpha-synuclein in lewy body disease.

Acta Neuropathol Commun

January 2025

Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.

Lewy bodies and neurofibrillary tangles, composed of α-synuclein (α-syn) and tau, respectively, often are found together in the same brain and correlate with worsening cognition. Human postmortem studies show colocalization of α-syn and tau occurs in Lewy bodies, but with limited effort to quantify colocalization. In this study, postmortem middle temporal gyrus tissue from decedents (n = 9) without temporal lobe disease (control) or with Lewy body disease (LBD) was immunofluorescently labeled with antibodies to phosphorylated α-syn (p-α-syn), tau phosphorylated at Ser202/Thr205 (p-tau), or exposure of tau's phosphatase-activating domain (PAD-tau) as a marker of early tau aggregates.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!